Bone Density in Adolescents Treated with a GnRH Agonist and Add-Back Therapy for Endometriosis

Amy D Divasta, Divasta AD, Laufer MR, Marc R Laufer, Catherine M Gordon, Gordon CM
Journal of Pediatric and Adolescent Gynecology · 2007 · vol. 20(5) , pp. 293–297 · doi:10.1016/j.jpag.2007.04.008 · PMID:17868896 · PMC3195423 · W2061551354
article OA: closed CC0 ⤵ 39 in-corpus citations
📄 Open PDF View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

This study evaluated bone mineral density in adolescents receiving GnRH agonist plus add-back therapy for endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Study objectiveTo evaluate the bone density of adolescents with endometriosis treated with a GnRH-agonist and "add-back" therapy with norethindrone acetate.DesignRetrospective chart review.SettingPediatric gynecology clinic at a tertiary care center.Participants36 adolescents, ages 13 to 21 years, with endometriosis.Main outcome measuresBone mineral density (BMD, g/cm(2)) by dual energy x-ray absorptiometry (DXA); BMD Z-scores of hip and spine.ResultsThe mean BMD Z-score at the total hip was -0.24 +/- 1.0, with a range of -2.4 to 1.7. At this site, 6 subjects had a BMD Z-score between -1.0 and -2.0 SD, while 2 had a Z-score < or = -2.0 SD. The mean BMD Z-score at the lumbar spine was 0.55 +/- 1.1, with a range of -2.8 to 1.4. At the spine, 11 subjects had a BMD Z-score between -1.0 and -2.0 SD, while 3 had a Z-score < or = -2.0 SD. There was no correlation noted between duration of therapy with the GnRH-agonist plus add-back and BMD at the hip or spine.ConclusionBMD at the hip was normal in most adolescents with endometriosis who were receiving a GnRH-agonist plus add-back therapy with norethindrone acetate. Almost one third of subjects exhibited skeletal deficits at the spine. These data suggest that BMD should be carefully monitored in adolescents receiving treatment with GnRH agonists.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Bone Density Bone Density Endometriosis Gonadotropin-Releasing Hormone Leuprolide Norethindrone Absorptiometry, Photon Adolescent Adult Cohort Studies Endometriosis Female Gonadotropin-Releasing Hormone Hip Hip Humans Leuprolide Lumbar Vertebrae Lumbar Vertebrae Norethindrone

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (26)

Cited by (39)

Source provenance

europepmc
last seen: 2026-07-28T06:14:09.330459+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:14:48.452140+00:00
License: CC0 · commercial use OK